Baidu
map

Adv Funct Mater:纳米发电机控制的药物精准递送系统实现高效的肿瘤治疗

2019-02-20 佚名 北京纳米能源与系统研究所

随着科技工业的发展以及老龄化社会的来临,癌症已经成为严重威胁人类健康的高发病症。2018年全球癌症患者约一千八百万人,而且每年新增癌症患者数目在不断增加,预计2030年患癌人数可达两千七百万。化学疗法是适用范围最广的癌症治疗手段,但它也存在着众所周知的问题,包括严重的毒副作用和较低的治疗效果。如作为化疗明星药物的阿霉素,常会引起心脏中毒、骨髓抑制、黏膜炎和秃头等一系列副作用。因此,关于肿瘤治疗的药

随着科技工业的发展以及老龄化社会的来临,癌症已经成为严重威胁人类健康的高发病症。2018年全球癌症患者约一千八百万人,而且每年新增癌症患者数目在不断增加,预计2030年患癌人数可达两千七百万。化学疗法是适用范围最广的癌症治疗手段,但它也存在着众所周知的问题,包括严重的毒副作用和较低的治疗效果。如作为化疗明星药物的阿霉素,常会引起心脏中毒、骨髓抑制、黏膜炎和秃头等一系列副作用。因此,关于肿瘤治疗的药物递送系统成为研究的热门。研究的目的是建立可以将药物定向输送到病灶部位的递送体系,以提高杀死肿瘤的效率并减少毒副作用的发生;更进一步地,如果能够实现药物在肿瘤部位的可控释放,这将会是更为优越的治疗手段。

红细胞具有长达120天的体内循环时间,良好的稳定性和伸缩性,无外移植物的免疫原性,是一种很好的肿瘤药物递送载体。同时,载药红细胞可对高压电场刺激产生响应性释放。但传统高压电源设备体积庞大,安全系数低,患者无法自主操作,这些因素阻碍了电场控制式药物递送系统在肿瘤治疗中的应用。

近日,中国科学院北京纳米能源与系统研究所李舟课题组完成了磁性互斥结构植入式摩擦纳米发电机的研制,并与中科院过程工程研究所研究员魏炜合作,将其用于控制载药红细胞在肿瘤部位的定点药物释放,实现了高效的肿瘤治疗效果。磁铁的同极斥力使得磁铁纳米发电机在封装和植入后仍然能够保持长久稳定的电能输出,纳米发电机的电场对装载阿霉素的红细胞膜具有精准的控制释放作用:施加电场时,药物释放加速为本底值的3-4倍;而在电场消失后,药物释放量迅速回归本底值,从而实现了药物的可控释放。将磁铁纳米发电机与叉指电极或微针电极结合,在二维肿瘤细胞、三维肿瘤球团以及小鼠体内的实体肿瘤三个层面,均实现了低浓度给药前提下的优异肿瘤治疗效果。尤其是在活体实验中,该纳米发电机与微针电极相结合的药物递送和释放系统,显着延长了荷瘤小鼠的生存寿命,并且对荷瘤小鼠毒副作用更低。基于磁性互斥结构纳米发电机微型化和高电压低电流输出的特点,该药物可控释放系统可安全地作为穿戴式或植入式电源应用于实际的医疗场景,为可控药物递送系统以及肿瘤治疗提供新的解决方案。

相关研究成果以Highly Efficient In Vivo Cancer Therapy by an Implantable Magnet Triboelectric Nanogenerator 为题发表在国际学术期刊《先进功能材料》(Advanced Functional Materials)上。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1304104, encodeId=3cf51304104ee, content=<a href='/topic/show?id=c5558298426' target=_blank style='color:#2F92EE;'>#肿瘤治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82984, encryptionId=c5558298426, topicName=肿瘤治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403382, encodeId=7f90140338257, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568558, encodeId=85aa1568558d4, content=<a href='/topic/show?id=838794862d0' target=_blank style='color:#2F92EE;'>#递送系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94862, encryptionId=838794862d0, topicName=递送系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68f115392320, createdName=lingaifan, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361151, encodeId=61c5361151d1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Wed Feb 20 23:08:31 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361144, encodeId=f356361144c5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Feb 20 22:02:06 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1304104, encodeId=3cf51304104ee, content=<a href='/topic/show?id=c5558298426' target=_blank style='color:#2F92EE;'>#肿瘤治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82984, encryptionId=c5558298426, topicName=肿瘤治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403382, encodeId=7f90140338257, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568558, encodeId=85aa1568558d4, content=<a href='/topic/show?id=838794862d0' target=_blank style='color:#2F92EE;'>#递送系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94862, encryptionId=838794862d0, topicName=递送系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68f115392320, createdName=lingaifan, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361151, encodeId=61c5361151d1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Wed Feb 20 23:08:31 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361144, encodeId=f356361144c5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Feb 20 22:02:06 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1304104, encodeId=3cf51304104ee, content=<a href='/topic/show?id=c5558298426' target=_blank style='color:#2F92EE;'>#肿瘤治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82984, encryptionId=c5558298426, topicName=肿瘤治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403382, encodeId=7f90140338257, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568558, encodeId=85aa1568558d4, content=<a href='/topic/show?id=838794862d0' target=_blank style='color:#2F92EE;'>#递送系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94862, encryptionId=838794862d0, topicName=递送系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68f115392320, createdName=lingaifan, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361151, encodeId=61c5361151d1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Wed Feb 20 23:08:31 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361144, encodeId=f356361144c5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Feb 20 22:02:06 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1304104, encodeId=3cf51304104ee, content=<a href='/topic/show?id=c5558298426' target=_blank style='color:#2F92EE;'>#肿瘤治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82984, encryptionId=c5558298426, topicName=肿瘤治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403382, encodeId=7f90140338257, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568558, encodeId=85aa1568558d4, content=<a href='/topic/show?id=838794862d0' target=_blank style='color:#2F92EE;'>#递送系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94862, encryptionId=838794862d0, topicName=递送系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68f115392320, createdName=lingaifan, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361151, encodeId=61c5361151d1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Wed Feb 20 23:08:31 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361144, encodeId=f356361144c5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Feb 20 22:02:06 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2019-02-20 orangesking

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1304104, encodeId=3cf51304104ee, content=<a href='/topic/show?id=c5558298426' target=_blank style='color:#2F92EE;'>#肿瘤治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82984, encryptionId=c5558298426, topicName=肿瘤治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1403382, encodeId=7f90140338257, content=<a href='/topic/show?id=ebbde6353be' target=_blank style='color:#2F92EE;'>#精准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76353, encryptionId=ebbde6353be, topicName=精准)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epQX9hfEIBiaPg0e9KvLYVBCSGYydH6K6OQxBh3RaOC0TYP9HYy2v0XdHib1LFnZNU5Siak0P8oh8Aqw/132, createdBy=acd92440184, createdName=shijzhiewnjhch, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568558, encodeId=85aa1568558d4, content=<a href='/topic/show?id=838794862d0' target=_blank style='color:#2F92EE;'>#递送系统#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94862, encryptionId=838794862d0, topicName=递送系统)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68f115392320, createdName=lingaifan, createdTime=Fri Feb 22 12:36:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361151, encodeId=61c5361151d1, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Wed Feb 20 23:08:31 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361144, encodeId=f356361144c5, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Feb 20 22:02:06 CST 2019, time=2019-02-20, status=1, ipAttribution=)]
    2019-02-20 医者仁心5538

    学习了

    0

相关资讯

美国癌症死亡率25年狂降27%背后的残酷

2019年1月初,影响因子高达 244.585 的世界顶尖期刊 CA: A Cancer Journal for Clinicians 发布了最新版《癌症统计 2019》。报告显示,1991 年美国癌症死亡率为 215.1/10 万人,而接下来的 25 年里,这一比率稳步下降每年约 1.5 个百分点,到 2016 年降到 156/10 万人。也就是说在这 25 年间,美国癌症死亡率整体下降了

关注儿童癌症 我们可以做些什么?

国际抗癌联盟将每年的2月15日定为“国际儿童癌症日”。儿童癌症正侵蚀着孩子们的生命健康,我们可以做些什么?中国抗癌协会调查数据显示,儿童癌症已经成为除意外创伤外,造成儿童死亡的第二大原因。然而,儿童癌症在我国的公众了解度还较低,大多数人仅知道白血病,却不知道儿童恶性实体肿瘤的发病率已经高于白血病。重庆市肿瘤医院肿瘤放射治疗中心副主任谢悦介绍,儿童肿瘤主要包括白血病(血液系统肿瘤)、中枢神经系统的恶

疟原虫治疗癌症现场招募人满为患 真有那么神奇?

自2018年诺贝尔生理学或医学奖授予癌症免疫治疗以来,关于癌症免疫治疗的各种“奇思妙想”便接踵而来,其中最令人关注的当属——疟原虫治疗癌症。对此很多人表示质疑,这个曾经让人类害怕的“大魔头”,真的能对战癌症?2月14日,中国科学院广州生物医药与健康研究院研究员陈小平的“疟原虫治疗癌症”的研究,在云南省昆明市第四人民医院肿瘤科开始招募患者,现场人潮涌动,负责咨询的医生被团团围住,护士告诉记者,“目前

虐原虫治愈癌症?这锅,中医不背!

广东这片土地似乎从来就不少得了新闻热点。前几天,据说人民日报的公众号报道了某位广东医学科研人员经过几乎毕生努力,凭借以毒攻毒的理念,结合自己读大学的时候在医学课堂上的脑子一闪,还真闪出思想火花来了——运用虐原虫“以毒攻毒”来治疗癌症,据说还是取得了一定的效果,十个实验参与人员,据说有相当比例的成功率 居然有两个癌症患者治疗“明显有效”,别说对医疗知识一知半解的百姓,就是医学专业人员也一样“欢欣鼓舞

Cancer:多一项健康生活方式,癌症风险降6%

随着生活方式的改变,癌症正逐渐成为我国居民生命与健康的主要威胁。数据统计显示:2015年全球共有1750万人罹患癌症,死亡人数高达870万人。而我国癌症发病和死亡病例分别占到全球总数的21.8%和26.9%。我国因癌症死亡人数已从1990年的150万人攀升至2015年的280万人。

Cancer Res:建立免疫监视系统预防癌症发生

经过近百年的努力,直至近年来以CTLA-4,PD-1通路为代表的免疫检查点抑制剂和CAR-T的成功,让免疫治疗在人类抗癌进程的春天里百花齐放,方兴未艾!肿瘤免疫疗法已成为未来“治愈”癌症的希望。因为最强大的抗癌力量,不是来自药物,也不是手术或者放疗,而是我们自身强大的免疫系统。

Baidu
map
Baidu
map
Baidu
map